BrainsWay (BWAY) vs Tactile Systems Technology (TCMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Tactile Systems Technology (TCMD) has outperformed BrainsWay (BWAY) over the past year, gaining 48.5% versus a gain of 47.8%. Over five years, BWAY leads with a +193.7% price change compared with -37.7% for TCMD. Tactile Systems Technology is the larger company by market cap ($501.1 million vs $461.7 million), about 1.1 times the size.
On valuation, Tactile Systems Technology trades at a lower forward P/E (15.2x vs 22.6x for BrainsWay).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BWAY | TCMD |
|---|---|---|
| Share price | $11.47 | $22.12 |
| Market cap | $461.70M | $501.07M |
| 1-day change | -1.29% | +0.45% |
| YTD return | +20.61% | -23.72% |
| 1-year return | +47.76% | +48.46% |
| 5-year return | +193.73% | -37.69% |
| P/E ratio (TTM) | 49.87 | 20.48 |
| Forward P/E | 22.64 | 15.20 |
| EPS (TTM) | $0.23 | $1.08 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.40 | $37.77 |
| 52-week low | $7.14 | $14.00 |
| Distance from 52-week high | -34.08% | -41.44% |
| Analyst consensus | none | none |
| Avg. price target upside | +68.00% | +76.31% |
| Average volume | 120.49K | 294.43K |
| Shares outstanding | 40.25M | 22.65M |
| Employees | 129 | 1,086 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BrainsWay trades at a higher earnings multiple (49.9x vs 20.5x trailing P/E).
About BrainsWay
BWAY stock →BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally.
Health Care · Medical/Dental Instruments · 129 employees
About Tactile Systems Technology
TCMD stock →Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds.
Health Care · Medical/Dental Instruments · 1,086 employees
BWAY vs TCMD FAQ
Which is bigger, BrainsWay or Tactile Systems Technology?
Tactile Systems Technology (TCMD) is larger, with a market capitalization of $501.07M compared with $461.70M for BrainsWay (BWAY).
Which stock has performed better over the past year, BWAY or TCMD?
TCMD returned +48.46% over the past 12 months, compared with +47.76% for BWAY (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, BWAY or TCMD?
TCMD has the lower trailing P/E at 20.5, versus 49.9 for BWAY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are BrainsWay and Tactile Systems Technology in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.